What the handover must contain before follow-up can be planned
A follow-up plan is only as good as the record behind it. Brain metastases are rarely a single event: they sit inside a longer cancer history, and the treating team needs to see that whole arc rather than a snapshot of the most recent scan. If the handover is incomplete, the new team may repeat tests that already exist, or propose a schedule that does not match what has already been done.
The first document is the primary cancer record: the original pathology report, the date and site of diagnosis, and the treatments already given for the primary disease. The second is the brain-specific history: when brain involvement was identified, how it was treated, and what the response was. The third is the current systemic plan, because brain-directed care and systemic therapy interact and are rarely managed in isolation.
Imaging matters as much as reports. A single recent MRI may show the current state, but follow-up decisions often depend on comparison. Ask whether the original imaging files, not only the written reports, can be shared in a format the receiving hospital can open. If the files cannot travel, the reports still help, but the new team should know that comparison may be limited.
This is a records question before it is a clinical one. The patient or family can assemble the file, but only the treating clinicians can say whether it is sufficient for their assessment. A useful habit is to keep a one-page summary at the front: diagnosis dates, treatments received, current medicines, allergies and the main question you want answered.
Who owns follow-up after you return home
A frequent gap in cross-border cancer care is not the treatment itself but the question of who is responsible afterwards. Before leaving China, ask the treating team to state, in writing, what they will provide after discharge: copies of imaging, a discharge summary, the proposed follow-up interval and the specific findings they want monitored.
Then ask your home oncology team what they are willing to take on. Some clinicians will accept a shared-care arrangement; others will want to review the records and make their own plan. Neither response is wrong, but you need to know which one applies before you travel, because it changes what you ask the China team to prepare.
If the two systems use different imaging protocols or reporting styles, that is normal. The practical question is whether the home team can access the images and whether they accept the China reports as a baseline. If they cannot, ask what they would need instead. This is an administrative conversation, not a clinical judgement, and it is better had before the flight than after.
Keep the contact details of both teams in one place, and confirm who will send records to whom. A named person on each side, even a coordinator rather than a clinician, reduces the chance that a scan result sits unread in an inbox.
What a follow-up schedule can and cannot tell you
Patients often ask for a fixed follow-up schedule before treatment begins. It is reasonable to want one, but the honest answer is that the interval depends on the individual treatment plan, the type of brain-directed therapy used and how the disease behaves over time. Radiotherapy, for example, uses radiation to treat cancer, and the technique and schedule depend on the individual treatment plan. That same principle applies to follow-up: it is set by the treating team, not by a general rule.
What you can ask for is the logic behind the proposed schedule. Why this interval? What would trigger an earlier scan? What symptoms should prompt contact before the next appointment? These questions produce useful answers even when the exact dates are still provisional.
It also helps to separate the two streams of follow-up. Brain imaging follows one rhythm; systemic cancer care follows another. If the two are managed by different departments, ask how they will communicate with each other. A follow-up plan that only covers one stream can leave the other unmonitored.
Do not treat a proposed schedule as a guarantee. Schedules change when scans change, when symptoms appear or when systemic treatment is adjusted. The value of the plan is that it gives both teams a shared reference point to revise.
Questions to ask before discharge from China
The discharge conversation is the best opportunity to close information gaps, because both the treating team and the records are in one place. Prepare the questions in advance and write down the answers rather than relying on memory.
Ask what the discharge summary will contain and whether it will be available in English. Ask which imaging will be provided, in what format, and whether the original files or only the reports can be released. Ask who to contact if a question arises after you return home, and through which channel.
Ask the treating team to state what they consider the key findings to monitor, in plain language. This is not a request for a prognosis; it is a request for the specific observations that should prompt a call. It helps the home team understand what the China clinicians were watching for.
Finally, ask what remains uncertain. Every handover has gaps, and naming them is more useful than pretending they do not exist. If a test result is pending, or a decision was deferred, that should be written down so the home team knows it is outstanding.
- What will the discharge summary include, and in which language?
- Which imaging files will be released, and in what format?
- Who is the named contact after discharge, and how do we reach them?
- What findings should prompt an earlier review?
- What results or decisions are still pending?
Keeping two health systems aligned over months and years
Long-term follow-up after brain metastases care is a coordination problem as much as a clinical one. Records move slowly, departments change, and the person who understood the original plan may not be the person you see at the next appointment. A simple shared folder, whether physical or digital, keeps the history intact.
Include in that folder the original pathology, the brain treatment summary, the most recent imaging reports, the current medication list and the contact details of both teams. Update it after each appointment. When a new clinician joins the picture, the folder does the explaining.
It also helps to keep a short written record of what changed and why. If a scan showed stability, note it. If a treatment was adjusted, note the reason. Over a long follow-up, these notes prevent the same ground being covered twice and make it easier for any clinician to pick up the thread.
Where language is a barrier, ask whether interpretation is available for follow-up appointments, not only for the initial consultation. A follow-up visit is often shorter and more technical, and misunderstandings there can be costly.
When follow-up questions need a China-based answer
Some questions cannot be resolved at home: whether a particular imaging technique is available, whether a specialist will review records remotely, or how a specific hospital handles follow-up for international patients. These are practical questions about care in China, and they are best asked directly rather than assumed.
If you are considering radiotherapy as part of brain metastases care in China, the relevant service reference explains how precision radiotherapy is planned and delivered. It is a starting point for the conversation, not a substitute for the treating team's assessment of your individual case.
For an initial enquiry, a short summary is enough: the diagnosis, the treatments already received, the main question and the records you can share. You do not need to send a complete medical archive at first contact, and an enquiry does not commit you to any paid service. The hospital decides whether it can accept the case and what it recommends.
The next step is to gather the primary cancer records, the brain treatment history and the most recent imaging reports, then ask the receiving team what they need to plan follow-up. That single action resolves more uncertainty than any general schedule.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.